For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
Scope of the Report:
This report focuses on the Olanzapine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2011, the Lilly's patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years.
At present, the United States is the largest producer and consumer of the olanzapine. Almost all of the olanzapine are used for manufacturing the olanzapine tablets products, most of the olanzapine producers manufacture the olanzapine for self-use, only few for export. Lilly is the largest producer and dominants the high-end field. The rest of manufacturers manufactures the generic olanzapine products, facing the low-end market, like Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals and Zhejiang Langhua Pharmaceuticals etc. Canada India Israel and China play the important roles in the olanzapine market. But to the olanzapine tablets market, USA Japan and Europe are the most important consumers.
The worldwide market for Olanzapine is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 210 million US$ in 2023, from 180 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Apotex Inc.
- Mylan Pharmaceuticals
- Par Pharmaceutical
- Aurobindo Pharma
- Torrent Pharmaceuticals
- Jubilant Lifesciences
- Sun Pharmaceutical
- Hansoh Pharmaceutical
- WATSON Pharmaceuticals(Changzhou)
- Zhejiang Langhua Pharmaceuticals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Patent Type
- Generics Type
Market Segment by Applications, can be divided into
- Olanzapine Tablets
- Other Medicine
There are 15 Chapters to deeply display the global Olanzapine market.
Chapter 1, to describe Olanzapine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Olanzapine, with sales, revenue, and price of Olanzapine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Olanzapine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Olanzapine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Olanzapine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source